Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31

by Business Wire • 2024/07/10 • 0 Comments

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release second quarter 2024 financial results after the market close on Wednesday, July 31, 2024. The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PT (4:30 p.m. ET) on July 31, 2024. A link to the

← Be Alert for Conjunctivitis: New Human Cases of H5N1 Bird Flu

Kopin Hosts ‘Vision System Demo Days’ Event in NYC to Unveil and Showcase Transformative Wearable Vision and Software Solutions for Defense, Medical and Consumer Applications →

Post navigation